Merion Revenue Growth Rates (EWLU), Current and Historic Growth - CSIMarket
CSIMarket
 


Merion Inc.  (EWLU)
 

EWLU's Revenue Growth by Quarter and Year

Merion's Revenue results by quarter and year




EWLU Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.08
1st Quarter March 0.15
FY 0.23

EWLUs Annual Revenue
Merion's Revenue in the fiscal year 2021 $ 1.48 millions
Merion's Revenue in the fiscal year 2020 $ 0.44 millions
Merion's Revenue in the fiscal year 2019 $ 1.81 millions
Merion's Revenue in the fiscal year 2018 $ 0.38 millions
Merion's Revenue in the fiscal year 2017 $ 0.76 millions




EWLU Revenue second quarter 2022 Y/Y Growth Comment
Merion Inc. reported drop in Revenue in the second quarter 2022 by -89.28% to $ 0.08 millions, from the same quarter in 2021.
The fall in the second quarter 2022 Merion Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 275.44%.

Looking into second quarter 2022 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue growth. While Merion Inc.' s Revenue meltdown of -89.28% ranks overall at the positon no. 4008 in the second quarter 2022.




EWLU Revenue ( Y/Y Growth %) 2022
2021 2020 2019
4th Quarter December - -63.33 % 275 % -27.27 %
3rd Quarter September - 325 % -60 % 100 %
2nd Quarter June -89.28 % 2433.33 % -97.97 % 886.67 %
1st Quarter March -65.91 % 528.57 % -53.33 % 150 %
FY   - 236.36 % -75.69 % -

Financial Statements
Merion's second quarter 2022 Revenue $ 0.08 millions EWLU's Income Statement
Merion's second quarter 2021 Revenue $ 0.76 millions Quarterly EWLU's Income Statement


EWLU Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
4th Quarter December - -35.29 % 650 % -20 %
3rd Quarter September - -77.63 % 33.33 % -93.24 %
2nd Quarter June -45.68 % 72.73 % -57.14 % 886.67 %
1st Quarter March 36.36 % 46.67 % -12.5 % 36.36 %
FY (Year on Year)   - 236.36 % -75.69 % -




Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #201
Overall #4008

Revenue Y/Y Growth Statistics
High Average Low
2513.33 % 275.44 % -98.03 %
(Jun 30 2021)   (Jun 30 2020)
Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #201
Overall #4008
Revenue Y/Y Growth Statistics
High Average Low
2513.33 % 275.44 % -98.03 %
(Jun 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merion's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
895.87 % 100.77 % -93.38 %
(Jun 30 2019)  


EWLU's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2022 Merion Inc. disclosed fall in Revenue from the first quarter by -45.68% to $ 0.08 millions, from $ 0.15 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2022 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Merion's Revenue growth quarter on quarter, overall rank is 4280.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #17
Retail Sector #215
Overall #4280
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #17
Retail Sector #215
Overall #4280
Revenue Q/Q Growth Statistics
High Average Low
895.87 % 100.77 % -93.38 %
(Jun 30 2019)  


EWLU's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2022 Merion Inc. disclosed fall in Revenue from the first quarter by -45.68% to $ 0.08 millions, from $ 0.15 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2022 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Merion's Revenue growth quarter on quarter, overall rank is 4280.


Merion's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ 0.51 $ 1.19 $ 1.48 $ 1.67 $ 1.54
Y / Y Revenue Growth (TTM) -66.76 % 47.4 % 237.35 % 655.2 % 456 %
Year on Year Revenue Growth Overall Ranking # 71 # 791 # 124 # 61 # 60
Seqeuential Revenue Change (TTM) -57.04 % -19.54 % -11.23 % 8.32 % 90.55 %
Seq. Revenue Growth (TTM) Overall Ranking # 434 # 3538 # 3508 # 989 # 73


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2022 Merion reported a sharp drop in Revenue by -66.76% year on year, to $1 millions, compare to the 47.4% growth at Mar 31 2022.

Merion Inc. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 791.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 3
Retail Sector # 1
Overall # 71

Revenue TTM Y/Y Growth Statistics
High Average Low
3121.09 %
362.31 %
-92.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 12
S&P 500 # 434
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2022 Merion reported a sharp drop in Revenue by -66.76% year on year, to $1 millions, compare to the 47.4% growth at Mar 31 2022.

Merion Inc. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 791.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 3
Retail Sector # 1
Overall # 71

Revenue TTM Y/Y Growth Statistics
High Average Low
3121.09 %
362.31 %
-92.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 12
S&P 500 # 434




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EWLU's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue sharp drop for the quarter ending Jun 30 2022 within Retail SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
Winc Inc -0.05%$ -0.051 millions
1stdibs com Inc -0.50%$ -0.498 millions
Ll Flooring Holdings Inc -0.81%$ -0.805 millions
Penske Automotive Group Inc -1.15%$ -1.153 millions
Gold com Inc -1.18%$ -1.175 millions
Live Ventures Inc-1.20%$ -1.195 millions
Sunstock Inc -1.44%$ -1.443 millions
Party City Holdco Inc -1.55%$ -1.549 millions
Autonation Inc -1.56%$ -1.565 millions
Charles and Colvard Ltd -4.35%$ -4.348 millions
Sally Beauty Holdings Inc -5.96%$ -5.959 millions
Petiq Inc -7.01%$ -7.010 millions
Climb Global Solutions Inc -9.94%$ -9.936 millions
Herbalife Ltd -10.28%$ -10.282 millions
The Odp Corporation-11.02%$ -11.024 millions
Cosmos Health Inc -11.04%$ -11.035 millions
Petmed Express Inc -11.51%$ -11.505 millions
Qvc inc -13.96%$ -13.957 millions
Wayfair inc -14.87%$ -14.870 millions
Qvc Group Inc -15.72%$ -15.725 millions
Aiadvertising Inc-18.93%$ -18.931 millions
The Beachbody Company Inc -19.71%$ -19.709 millions
Grove Collaborative Holdings Inc -19.94%$ -19.939 millions
Nu Skin Enterprises Inc -20.37%$ -20.373 millions
Blue Line Protection Group Inc -21.37%$ -21.370 millions
Global Ai Inc -33.33%$ -33.333 millions
Vroom Inc -37.61%$ -37.608 millions
Takung Art Co Ltd-39.29%$ -39.294 millions
Pony Group Inc -40.75%$ -40.750 millions
Lazydays Holdings Inc -42.14%$ -42.137 millions


About Merion Revenue Growth Rates (EWLU), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Merion Inc (CIK 1517498).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-22-007147
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Merion Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.